Our study demonstrates that both physiological (mice, primary murine cells, humans) and pathological (tumor cells) DKK1 activity fuels inflammatory cytokine production, which contributes to maladaptive inflammation in disease. This evidence concerns the gene DKK1 and neoplasm.